Single-Cell Analysis Uncovers Regulatory Program in Rare Leukemia

Oct

Novel Applications of RNA-based Precision Oncology: From Drug Tolerability to Immunogenomics

This webinar, Part 3 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss novel and emerging applications of RNA-based genomic analysis in precision oncology, form characterizing the tumor microenvironment to informing the development of immuno-oncology treatments.

Oct

Featured Webinar

Application of ctDNA Analysis to Detect MRD and Predict Recurrence in Colorectal Cancer

Circulating tumor DNA (ctDNA) can allow clinicians and researchers to better understand which patients are at high risk of recurrence and should be offered intensified chemotherapy or selected for clinical trials.

Oct

Featured Webinar

A Comparison of cfDNA Approaches to Guide Targeted Therapy in NSCLC

In non-small cell lung cancer (NSCLC), early detection of emerging resistance mutations such as EGFR T790M is important in order to determine the appropriate targeted therapeutic strategy.

Oct

Featured Webinar

Crystal Digital PCR for Accurate Chimerism Monitoring after Stem Cell Transplantation

This webinar will discuss a new method that relies on Crystal digital PCR from Stilla Technologies to monitor chimerism in patients after stem cell transplantation, which is a key part of surveillance for impending clinical relapse.

Menu

Single-Cell Analysis Uncovers Regulatory Program in Rare Leukemia

To read the full story....

Breaking News

M2Gen Expands Partnership With Discovery Life Sciences

Mutations in Type I Interferon Immunity Genes Underlie Severe COVID-19

Palmetto Expands Coverage for Decipher Biosciences Prostate Cancer Test

Cepheid Multiplex SARS-CoV-2, Flu, RSV Test Nabs FDA Emergency Use Authorization

ASU Team Wins $6M in Government Funding to Develop Rapid Saliva Testing System for Coronavirus

In Brief This Week: Fluidigm, Thermo Fisher Scientific, Veracyte, and More

Recent Headlines from
Precision Oncology News

Novartis Triplet Therapy Failure Raises Questions for Other Combos; Subgroups May Still Benefit

Relay Therapeutics Uses Protein Motion Simulation to Develop Highly Selective Precision Cancer Drugs

Growing Data on Vitrakvi Demonstrate Enduring Activity Across Variety of NTRK-Positive Tumor Types

Merck's Keytruda, BMS's Opdivo Prolong Survival for Patients With Gastroesophageal Cancers

Roche's Ipatasertib, Anti-Androgen Therapy Improves Outcomes in Prostate Cancer With PTEN Loss

Featured White Papers

Novel Applications of RNA-based Precision Oncology: From Drug Tolerability to Immunogenomics

Application of ctDNA Analysis to Detect MRD and Predict Recurrence in Colorectal Cancer

A Comparison of cfDNA Approaches to Guide Targeted Therapy in NSCLC

Crystal Digital PCR for Accurate Chimerism Monitoring after Stem Cell Transplantation

What's Popular?

Natera Cancer Liquid Biopsy Test Coverage to Expand Under New Draft LCD

Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test

Palmetto Expands Coverage for Decipher Biosciences Prostate Cancer Test

CRISPR Screen Uncovers Genes That Help Cancer Cells Evade Immune System

Metastatic Cancer Treatment Markers Identified in Clinical WGS Study

Sponsorships